Background: Urinary incontinence is defined as the involuntary loss of urine, which
can affect up to 45% of women after menopause. Radiofrequency is a non-invasive
procedure that involves the application of an electromagnetic wave that through
heat generation promotes neocollagenesis and neoeslatinogenesis in the vaginal
epithelium. This energy-based technology has been studied as a potential
alternative for the treatment of genitourinary syndrome of menopause and
urinary incontinence. Objective: To review the recent literature (from
2020 to June 2022) on the use of transvaginal radiofrequency in the treatment
of stress urinary incontinence, by searching articles at databases of Capes,
PubMed Cochrane and Scielo. Methods: The descriptor terms “Urinary
Incontinence/therapy”[Majr]
AND “Urinary Incontinence, Stress/therapy”[Majr] AND RADIOFREQUENCY-Search Results-PubMed, [“woman” OR “women”] AND [“urinary incontinence” OR “stress urinary
incontinence”] AND Radiofrequency were used, with a filter for the period 2020
to 2022. Conclusion: The studies evaluated in this review demonstrated
significant results of radiofrequency in the resolution or reduction of
complaints of women with urinary incontinence, especially stress urinary
incontinence, but most of these studies presented a low methodological quality.
There is, therefore, a lack of studies with longer follow-ups, evaluation of
cost-effectiveness, randomized clinical trials with objective outcomes and the
use of validated questionnaires with international acceptance.
References
[1]
Ribeiro, F.C., Silva, M.L.A., Silva, M.A.P.S.D., Gouveia, G.P.M., Eufrásio, L.S. and Micussi, M.T.A.B.C. (2021) Use of Radiofrequency for the Treatment of Urinary Incontinence in Women: A Systematic Review. Revista da Associação Médica Brasileira, 67, 1857-1862. https://doi.org/10.1590/1806-9282.20210266
[2]
Haylen, B.T., de Ridder, D., Freeman, R.M., Swift, S.E., Berghmans, B., Lee, J., Monga, A., Petri, E., Rizk, D.E., Sand, P.K. and Schaer, G.N. (2010) An International Urogynecological Association (IUGA)/International Continence Society (ICS) Joint Report on the Terminology for Female Pelvic Floor Dysfunction. Neurourology and Urodynamics, 29, 4-20. https://doi.org/10.1002/nau.20798
[3]
Wu, J.M. (2021) Stress Incontinence in Women. The New England Journal of Medicine, 384, 2428-2436. https://doi.org/10.1056/NEJMcp1914037
[4]
Kent, D.E. and Bernardy, J. (2020) Safety and Mechanism of Action of Noninvasive Radiofrequency Treatment for Vaginal Laxity: Histological Study in the Swine Vaginal Model. Journal of Cosmetic Dermatology, 19, 1361-1366.
https://doi.org/10.1111/jocd.13159
[5]
Weiner, S.F. (2019) Radiofrequency Microneedling: Overview of Technology, Advantages, Differences in Devices, Studies, and Indications. Facial Plastic Surgery Clinics of North America, 27, 291-303. https://doi.org/10.1016/j.fsc.2019.03.002
[6]
Slongo, H., Lunardi, A.L.B., Riccetto, C.L.Z., Machado, H.C. and Juliato, C.R.T. (2022) Microablative Radiofrequency versus Pelvic Floor Muscle Training for Stress Urinary Incontinence: A Randomized Controlled Trial. International Urogynecology Journal, 33, 53-64. https://doi.org/10.1007/s00192-021-04758-2
[7]
Sarmento, A.C.A., Fernandes, F.S., Costa, A.P.F., Medeiros, K.S., Crispim, J.C. and Gonçalves, A.K. (2021) Microablative Fractional Radiofrequency for the Genitourinary Syndrome of Menopause: Protocol of Randomised Controlled Trial. BMJ Open, 11, e046372. https://doi.org/10.1136/bmjopen-2020-046372
[8]
Abdelaziz, A., Dell, J. and Karram, M. (2021) Transvaginal Radiofrequency Energy for the Treatment of Urinary Stress Incontinence: A Comparison of Monopolar and Bipolar Technologies in Both Pre- and Post-Menopausal Patients. Neurourology and Urodynamics, 40, 1804-1810. https://doi.org/10.1002/nau.24748
[9]
Pinheiro, C., Costa, T., Amorim de Jesus, R., Campos, R., Brim, R., Teles, A., Vilas Boas, A. and Lordêlo, P. (2021) Intravaginal Nonablative Radiofrequency in the Treatment of Genitourinary Syndrome of Menopause Symptoms: A Single-Arm Pilot Study. BMC Women’s Health, 21, Article No. 379.
https://doi.org/10.1186/s12905-021-01518-8
[10]
Mezzana, P., Garibay, I. and Fusco, I. (2022) Vaginal Bipolar Radiofrequency Treatment of Mild SUI: A Pilot Retrospective Study. Medicina (Kaunas), 58, 181.
https://doi.org/10.3390/medicina58020181
[11]
U.S. Food and Drug Administration (2018) Statement from FDA Commissioner Scott Gottlieb, M.D., on Efforts to Safeguard Women’s Health from Deceptive Health Claims and Significant Risks Related to Devices Marketed for Use in Medical Procedures for “Vaginal Rejuvenation”.
https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-efforts-safeguard-womens-health-deceptive-health-claims